http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3032341

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.|Research Support, U.S. Gov't, P.H.S.
endingPage 1604
issn 1538-8514
1535-7163
issueIdentifier 12
pageRange 1593-1604
publicationName Molecular Cancer Therapeutics
startingPage 1593
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f0a69b4112b88db05f2abdc65f725e4a
bibliographicCitation Burkhart DJ, Kalet BT, Coleman MP, Post GC, Koch TH. Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. Mol Cancer Ther. 2004 Dec;3(12):1593–604. PMID: 15634653.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da2ae4321858bd0ce4477bb31702405b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c726158e2c9d6f366b362c75d301fd76
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b663b6c99d52bb4a7bc69d6d904ba920
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8fda640685b77ae7b85fcde6f57bd14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c671713244f751685183c39ea180112c
date 2004-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/15634653
https://doi.org/10.1158/1535-7163.1593.3.12
isPartOf https://portal.issn.org/resource/ISSN/1535-7163
https://portal.issn.org/resource/ISSN/1538-8514
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin
discusses http://id.nlm.nih.gov/mesh/M0008753
http://id.nlm.nih.gov/mesh/M0028506
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0028407
http://id.nlm.nih.gov/mesh/M0418730
http://id.nlm.nih.gov/mesh/M0017642
http://id.nlm.nih.gov/mesh/M0016224
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D039302Q000378
http://id.nlm.nih.gov/mesh/D011355Q000627
http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D015195
http://id.nlm.nih.gov/mesh/D014407
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D004317Q000008
http://id.nlm.nih.gov/mesh/D005557Q000008
http://id.nlm.nih.gov/mesh/D002448
http://id.nlm.nih.gov/mesh/D019030Q000378
http://id.nlm.nih.gov/mesh/D010446Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010446Q000138
http://id.nlm.nih.gov/mesh/D020128
http://id.nlm.nih.gov/mesh/D002462Q000378
http://id.nlm.nih.gov/mesh/D019096Q000378
http://id.nlm.nih.gov/mesh/D001943Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1268124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b98ac0baf9d5adcc2dc9c0885c8cdd02
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a73b4feef7226074b49b42d83fadea5b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176873

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127648000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 67.